Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This image is advertising an OBN Digital event, a CEO Interview with Prof Adrian Hill, Head of Oxford's Jenner Institute. This event is taking place on 2nd February 2021 from 5:00 pm to 6:00 pm.

Join OBN for the session to learn directly from Professor Hill about the vaccine development, as well as:

  1. The background to the US six-week delay during the trials process
  2. The choice of AstraZeneca as a partner
  3. Confusion over the efficacy/ dosing communication and the real story on the half dose
  4. Thoughts on the government approach of only going initially with a single dose
  5. View on efficacy with mutating strains.

 There will also be time for audience questions at the end of the interview.

About the event: This session will be run in a live format using Zoom Webinar, with registration open for both OBN Members and Non-Members.  A live Q&A will follow the interview and audience members will be encouraged to send their questions during the event.

To register, click here